Skip Navigation LinksHome > May 2013 - Volume 19 - Issue 3 > Declining Differences in Response Rates with Antidepressants...
Journal of Psychiatric Practice:
doi: 10.1097/01.pra.0000430506.37144.d1
COLUMNS: Psychopharmacology

Declining Differences in Response Rates with Antidepressants versus Placebo: A Modest Proposal for Another Contributing Cause


Collapse Box


This column discusses declining differences in response rates between sequentially introduced selective serotonin reuptake inhibitors (SSRI) and placebo. Although discussions of this phenomenon in the literature have largely focused on increasing placebo response rates, the author proposes that another factor may be responsible. That factor is an order effect, meaning that response rates have been declining as a function of the number of SSRIs on the market when the next SSRI is in development. The rationale is that the pool of potential clinical trial participants likely to respond to a drug with this mechanism of action (MOA) becomes progressively smaller with the introduction of each new agent with the same MOA, because many patients will already have been treat- ed and responded to an earlier member of the class. This phenomenon is not limited to the SSRIs but generalizes to any class of treatments that shares the same MOA. (Journal of Psychiatric Practice 2013;19:227–233)

© 2013 by Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.